Pfizer begins clinical trials for COVID-19 vaccine designed especially to tackle Omicron
Pfizer has begun clinical trials for its new COVID-19 vaccine tailored to the Omicron variant. The company plans to have the shot available as early as March if it clear regulatory hurdles.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer and BioNTech Start Studies of Omicron-Specific VaccinePfizer and BioNTech announced today that they have started testing an Omicron-specific COVID-19 vaccine in healthy adults
Lire la suite »
Pfizer and BioNTech Start Studies of Omicron-Specific VaccinePfizer and BioNTech announced today that they have started testing an Omicron-specific COVID-19 vaccine in healthy adults
Lire la suite »
NSW Covid-19 update: Hazzard says it’s ‘ridiculous’ not enough people getting their booster – videoNSW health minister says in one hospital ‘there are seven people in ICU and not one of them has had the booster’
Lire la suite »
Tech & Science Daily: Lab tests show Omicron survives longer on skin and plasticJapanese researchers have discovered the Omicron covid variant can survive longer than earlier versions of the coronavirus on plastic surfaces and human skin.
Lire la suite »
Elton John's husband David Furnish's heartfelt tribute to star just days before devastating Covid setbackDavid Furnish celebrated Elton John’s return to the stage shortly before the singer tested positive for COVID-19
Lire la suite »